Increased Connective Tissue Growth Factor Relative
... Results Elevated Levels of CTGF Protein in CM Correlates With Myocardial Interstitial Fibrosis in Patients With Preserved Ejection Factor Clinical characteristics of the NF and DHF groups are summarized in Table S1. There were no significant differences in age, sex, clinical diagnosis, and frequency ...
... Results Elevated Levels of CTGF Protein in CM Correlates With Myocardial Interstitial Fibrosis in Patients With Preserved Ejection Factor Clinical characteristics of the NF and DHF groups are summarized in Table S1. There were no significant differences in age, sex, clinical diagnosis, and frequency ...
DOI: 10.1161/CIR.0b013e318212bb8b published online Mar 28
... This document was approved by the American College of Cardiology Foundation Board of Trustees and by the American Heart Association Science Advisory and Coordinating Committee, and the sections that have been updated are indicated with hyperlinks to the focused update where applicable. When citing t ...
... This document was approved by the American College of Cardiology Foundation Board of Trustees and by the American Heart Association Science Advisory and Coordinating Committee, and the sections that have been updated are indicated with hyperlinks to the focused update where applicable. When citing t ...
Coronary Artery Manifestations of€Fibromuscular Dysplasia
... while this new classification on the basis of angiographic appearance of a peripheral artery is straightforward, it has limited utility for classifying coronary ...
... while this new classification on the basis of angiographic appearance of a peripheral artery is straightforward, it has limited utility for classifying coronary ...
HRV Training Protocols
... sensors placed on a finger or earlobe, or on your chest and lower torso, or wrists to measure the time interval between each heartbeat. ...
... sensors placed on a finger or earlobe, or on your chest and lower torso, or wrists to measure the time interval between each heartbeat. ...
ACC/AHA 2002 Guideline Update for Exercise
... Class IIb: Usefulness/efficacy is less well established by evidence/opinion. ...
... Class IIb: Usefulness/efficacy is less well established by evidence/opinion. ...
Risk scores: a guide in clinical practice? Application of risk scores in
... in its choice of treatment. It has however been suggested before that physicians may have a skeptic attitude towards the use of risk scores in decision-making [4]. Although these instruments have been extensively validated and are recommended by renowned guidelines such as the European Society of Ca ...
... in its choice of treatment. It has however been suggested before that physicians may have a skeptic attitude towards the use of risk scores in decision-making [4]. Although these instruments have been extensively validated and are recommended by renowned guidelines such as the European Society of Ca ...
ACC/AHA 2002 Guideline Update for Exercise Testing
... been published regarding the usefulness of exercise testing for prediction of outcome in both symptomatic and asymptomatic patients. The usefulness of oxygen consumption measurements in association with exercise testing to identify patients who are candidates for cardiac transplantation has been rec ...
... been published regarding the usefulness of exercise testing for prediction of outcome in both symptomatic and asymptomatic patients. The usefulness of oxygen consumption measurements in association with exercise testing to identify patients who are candidates for cardiac transplantation has been rec ...
Exercise Testing: ACC/AHA 2002 Guideline Update for
... been published regarding the usefulness of exercise testing for prediction of outcome in both symptomatic and asymptomatic patients. The usefulness of oxygen consumption measurements in association with exercise testing to identify patients who are candidates for cardiac transplantation has been rec ...
... been published regarding the usefulness of exercise testing for prediction of outcome in both symptomatic and asymptomatic patients. The usefulness of oxygen consumption measurements in association with exercise testing to identify patients who are candidates for cardiac transplantation has been rec ...
NCD Watch August 2016
... Box 1: Major risk factors for atrial fibrillation Advancing age — Anyone can have atrial fibrillation, but the risk is greater as people age. For each advancing decade of age, the risk of developing atrial fibrillation are about doubled. 13 For example, men aged 75 to 79 were 2 times and more than 5 ...
... Box 1: Major risk factors for atrial fibrillation Advancing age — Anyone can have atrial fibrillation, but the risk is greater as people age. For each advancing decade of age, the risk of developing atrial fibrillation are about doubled. 13 For example, men aged 75 to 79 were 2 times and more than 5 ...
Assessment report on Leonurus cardiaca herba
... The main components of the essential oil from the herb were identified by GC-MS as transcaryophyllene (33.43%), alpha-humulene (21.49%) and germacrene-D (24.95%) (Almeida 2005). The herb contains furanic labdane diterpenes (Savona 1982, Satoh 2003). The occurrence of leonurin, 4-guanidinobutanol-(1) ...
... The main components of the essential oil from the herb were identified by GC-MS as transcaryophyllene (33.43%), alpha-humulene (21.49%) and germacrene-D (24.95%) (Almeida 2005). The herb contains furanic labdane diterpenes (Savona 1982, Satoh 2003). The occurrence of leonurin, 4-guanidinobutanol-(1) ...
Influence of pacing site on canine left ventricular contraction
... in the activation time of the ventricle with an accompanying prolongation of the QRS complex of the body surface electrogram (5, 10, 11, 15). Sonomicrometer and cineradiographic measurements have indicated significant and characteristic changes in the time course of local ventricular segmental wall ...
... in the activation time of the ventricle with an accompanying prolongation of the QRS complex of the body surface electrogram (5, 10, 11, 15). Sonomicrometer and cineradiographic measurements have indicated significant and characteristic changes in the time course of local ventricular segmental wall ...
Factors Influencing Infarct Size Following
... from 0.22 + 0.04 to 3.32 + 0.37 mv (SEM). Isoproterenol, ouabain, glucagon, bretylium, and tachycardia given prior to a repeated occlusion increased the severity and extent of ischemic injury, while propranolol decreased it. Elevation of arterial pressure with methoxamine reduced the occlusion-induc ...
... from 0.22 + 0.04 to 3.32 + 0.37 mv (SEM). Isoproterenol, ouabain, glucagon, bretylium, and tachycardia given prior to a repeated occlusion increased the severity and extent of ischemic injury, while propranolol decreased it. Elevation of arterial pressure with methoxamine reduced the occlusion-induc ...
ACC/AHA/ESC Guidelines for the Management of Patients
... 2. Acute Treatment.......................................................26 3. Long-Term Pharmacologic Therapy........................26 4. Catheter Ablation.....................................................28 5. Management of Patients With Asymptomatic Accessory Pathways......................... ...
... 2. Acute Treatment.......................................................26 3. Long-Term Pharmacologic Therapy........................26 4. Catheter Ablation.....................................................28 5. Management of Patients With Asymptomatic Accessory Pathways......................... ...
... 2. Acute Treatment.......................................................26 3. Long-Term Pharmacologic Therapy........................26 4. Catheter Ablation.....................................................28 5. Management of Patients With Asymptomatic Accessory Pathways......................... ...
Vitamin C prevents hyperoxia-mediated
... Eleven healthy subjects participated in this study (mean age 36 ⫾ 3 yr, 9 males, 2 females). All subjects were nonsmokers, and none were taking medications or vitamin supplements. Fifteen male patients with CHF also participated (mean age 55 ⫾ 3 yr, 9 patients in NYHA II, 6 patients in NYHA III). Th ...
... Eleven healthy subjects participated in this study (mean age 36 ⫾ 3 yr, 9 males, 2 females). All subjects were nonsmokers, and none were taking medications or vitamin supplements. Fifteen male patients with CHF also participated (mean age 55 ⫾ 3 yr, 9 patients in NYHA II, 6 patients in NYHA III). Th ...
what is biofeedback? - Mobile Health Consult
... sensors placed on a finger or earlobe, or on your chest and lower torso, or wrists to measure the time interval between each heartbeat. ...
... sensors placed on a finger or earlobe, or on your chest and lower torso, or wrists to measure the time interval between each heartbeat. ...
Evaluation of transmural distribution of viable muscle by - AJP
... been quantified and fully elucidated. To address this issue, we evaluated transmural myocardial strain profile (TMSP) in dogs with myocardial infarction using a newly developed tissue strain imaging. TMSP was obtained from the posterior wall at the epicardial left ventricular short-axis view in 13 a ...
... been quantified and fully elucidated. To address this issue, we evaluated transmural myocardial strain profile (TMSP) in dogs with myocardial infarction using a newly developed tissue strain imaging. TMSP was obtained from the posterior wall at the epicardial left ventricular short-axis view in 13 a ...
Age-related comorbidities that impact on wound healing
... persists longer. Estrogen can improve age-related impairment in healing in both men & women • Stress: diminishes inflammatory response and reduces the production of cytokines • Disease: presence of chronic disease tends to lead to slower healing (e.g. people with RA frequency of leg ulcers is 3 time ...
... persists longer. Estrogen can improve age-related impairment in healing in both men & women • Stress: diminishes inflammatory response and reduces the production of cytokines • Disease: presence of chronic disease tends to lead to slower healing (e.g. people with RA frequency of leg ulcers is 3 time ...
Improving Chronic Disease Management - Health
... “Today in the United States chronic disease is the major cause of disability, is the main reason why people seek health care, and consumes 70% of health care spending. With acute disease, the treatment aims at return to normal. With chronic disease, the patient’s life is irreversibly changed. Neithe ...
... “Today in the United States chronic disease is the major cause of disability, is the main reason why people seek health care, and consumes 70% of health care spending. With acute disease, the treatment aims at return to normal. With chronic disease, the patient’s life is irreversibly changed. Neithe ...
Management of atrial fibrillation-Review
... pressure. Since the effect of digoxin on ventricular rate is mediated by its vagotonic effect on the AV node, the onset of action could take several hours. For the same reason, digoxin is usually ineffective during acute settings with high catecholamines status, such as postoperative status, acute seps ...
... pressure. Since the effect of digoxin on ventricular rate is mediated by its vagotonic effect on the AV node, the onset of action could take several hours. For the same reason, digoxin is usually ineffective during acute settings with high catecholamines status, such as postoperative status, acute seps ...
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac
... Class IIb: Usefulness/efficacy is less well established by evidence/opinion. Class III: Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful. Levels of evidence for individual class assignments are desig ...
... Class IIb: Usefulness/efficacy is less well established by evidence/opinion. Class III: Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful. Levels of evidence for individual class assignments are desig ...
Pericardial Disease: Etiology, Pathophysiology
... evidence-based data derive only from guidelines published by the European Society of Cardiology (ESC)1 and reports of large series from centers to which many patients with pericardial disease are referred. Pericardial heart disease is much less common than heart disease, originating with primary dis ...
... evidence-based data derive only from guidelines published by the European Society of Cardiology (ESC)1 and reports of large series from centers to which many patients with pericardial disease are referred. Pericardial heart disease is much less common than heart disease, originating with primary dis ...
Patient-Specific Modeling of Blood Flow and Pressure in Human
... range. However, the right coronary flow does not decrease in systole because the right ventricle operates in a lower pressure range than the left ventricle.17 Even the maximum right ventricular pressure is one-fifth of the average aortic pressure.17 To accommodate the change in the intramyorcardial pr ...
... range. However, the right coronary flow does not decrease in systole because the right ventricle operates in a lower pressure range than the left ventricle.17 Even the maximum right ventricular pressure is one-fifth of the average aortic pressure.17 To accommodate the change in the intramyorcardial pr ...
Antihypertensive drug
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used drugs are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.Which type of medication to use initially for hypertension has been the subject of several large studies and resulting national guidelines. The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. The several classes of antihypertensives differ in side effect profiles, ability to prevent endpoints, and cost. The choice of more expensive agents, where cheaper ones would be equally effective, may have negative impacts on national healthcare budgets. As of 2009, the best available evidence favors the thiazide diuretics as the first-line treatment of choice for high blood pressure when drugs are necessary. Although clinical evidence shows calcium channel blockers and thiazide-type diuretics are preferred first-line treatments for most people (from both efficacy and cost points of view), an ACE inhibitor is recommended by NICE in the UK for those under 55 years old.